Grail is preparing to file for FDA approval of its Galleri test for detecting multiple cancers from a single blood test after seeing positive results in a second phase 3 trial. Galleri is a ...
Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback